Diagnostic Tests

Products Diagnostic Tests

Novel PCR Assay identifies more than 345 bacteria and fungi in clinical samples in only 6 hours

Neurological infections: UMD™ is a new PCR assay enabling culture-independent identification of more than 345 bacteria and fungi from CSF more

ELISA kits for the measurment of SDF-1/CXCL12

SDF-1α (CXCL12) is a CXC chemokine. The small basic protein (ca. 8 kDa) has no glycosylation site in its sequence. The homology properties of SDF-1α are unique among the chemokines more

News Diagnostic Tests

• Frost & Sullivan determines a real and urgent need for novel cancer diagnostics tests

  The range of potential therapeutic approaches available to treat cancer is expected to expand rapidly during the next decade. Current diagnostic technologies focus on detection and diagnosis of cancer using mainly blood, faeces, urine tests or genetic tests. Testing methods are now gradually moving more

• UGA researchers develop rapid diagnostic test for pathogens, contaminants
  

  Using nanoscale materials, researchers at the University of Georgia have developed a single-step method to rapidly and accurately detect viruses, bacteria and chemical contaminants. In a series of studies, the scientists were able to detect compounds such as lactic acid and the protein albumin in hi more

• Sebia partners with Inserm Transfert to develop a unique diagnostic test for haemoglobin diseases

  Sebia announced that it has entered into partnership with Inserm (the French National Institute of Health and Medical Research) and Inserm Transfert, its private subsidiary responsible for marketing the outcomes of its scientific research, to develop and commercialize a unique biological test for me more

White papers Diagnostic Tests

• Clinical Biomarkers: Novel Tools for Pharmacodynamic Applications
  

  Biomarkers are currently changing the way we diagnose and treat diseases. Today pharmacodynamic biomarkers are widely used in the industry elaborating optimal dosing of new drugs and predictive biomarkers have an enormous potential for companion diagnostics more

• Pathogen detection with VYOO(TM)
  

  Sepsis is the most common cause of death in hospitalized patients worldwide. Inadequate antibiotic therapy represents an independent determinant of patients' mortality. Promptness of pathogen detection and the appliance of appropriate antibiotics are the cornerstones of management of severe bacterial infections. Furthermore, resistance to antibiotics is an increasing public health problem that can be attributed largely to their overuse. Thus, rapid diagnostic tests with both superior positive and negative predictive values over current techniques are sorely needed. more

• Molecular diagnostic test applied to ascitic fluid
  

  Spontaneous bacterial peritonitis (SBP) is a common and life-threatening complication of patients with ascites and cirrhosis of the liver. The mortality accounts for up to 30-50% and such patients die within several hours after infection. An early diagnosis and subsequent antibiotic therapy are prerequisites for the survival of the patients. The clinical standard for a diagnosis of SBP is the increased number of polymorphic neutrophilic cells in the ascites (> 250/l), independent of the results obtained with ascites cultures. An increased cell count is not detectable in all patients. Positive ascites cultures are typically found in 40-90% of all SBP cases. more

Publications Diagnostic Tests

• eyeGENE®: A Vision Community Resource Facilitating Patient Care and Paving the Path for Research through Molecular Diagnostic Testing

  Abstract Molecular genetics and genomics are revolutionizing the study and treatment of inherited eye diseases. In recognition of the impact of molecular genetics on vision and ophthalmology, the National Eye Institute established the National Ophthalmic Disease Genotyping and Phenotyping Networ more

• Technological evolution of diagnostic testing in oncology

  Diagnostic testing has been improving the quality of cancer care. The dynamics of this field can be grasped through the application of innovation lifecycle models. Single testing, parallel testing and whole-genome sequencing are major technological evolutions. Given the increasing availability of bi more

• Measuring Coverage in MNCH: Accuracy of Measuring Diagnosis and Treatment of Childhood Malaria from Household Surveys in Zambia

  by Thomas P. Eisele, Kafula Silumbe, Josh Yukich, Busiku Hamainza, Joseph Keating, Adam Bennett, John M. Miller Background To assess progress in the scale-up of rapid diagnostic tests and artemisinin-based combination therapies (ACTs) across Africa, malaria control programs have increasingly reli more

Market studies Diagnostic Tests

• High-Growth Diagnostic Testing Markets

  There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade. The emphas more

• Metiscan, Inc. - Strategic SWOT Analysis Review

  Metiscan, Inc. (Metiscan) is a public company that is focused on healthcare related businesses. The company is a provider of web-based software applications for diagnostic imaging centers. The company's keystone product is a web-based radiology information system that interfaces Radiology Informatio more

• Companion Diagnostics in Personalized Medicine and Cancer Therapy

  A near-term market opportunity for cancer companion diagnostic tests exists in drug selection for cancer therapy. Co-development of molecular diagnostics and targeted therapeutics has already been proven to be a successful strategy in the development of novel anti-cancer drugs. Adoption of biomarker more

Websites Diagnostic Tests